KalVista Pharmaceuticals (KALV) Operating Leases (2019 - 2024)
Historic Operating Leases for KalVista Pharmaceuticals (KALV) over the last 5 years, with Q4 2024 value amounting to $4.4 million.
- KalVista Pharmaceuticals' Operating Leases changed N/A to $4.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.4 million, marking a year-over-year change of. This contributed to the annual value of $6.0 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q4 2024, KalVista Pharmaceuticals' Operating Leases is $4.4 million.
- KalVista Pharmaceuticals' Operating Leases' 5-year high stood at $6.9 million during Q3 2023, with a 5-year trough of $926000.0 in Q1 2020.
- In the last 4 years, KalVista Pharmaceuticals' Operating Leases had a median value of $4.6 million in 2024 and averaged $3.7 million.
- As far as peak fluctuations go, KalVista Pharmaceuticals' Operating Leases skyrocketed by 2127.43% in 2021, and later crashed by 2858.23% in 2024.
- Over the past 4 years, KalVista Pharmaceuticals' Operating Leases (Quarter) stood at $932000.0 in 2020, then rose by 20.49% to $1.1 million in 2021, then soared by 482.9% to $6.5 million in 2023, then tumbled by 32.22% to $4.4 million in 2024.
- Its last three reported values are $4.4 million in Q4 2024, $4.7 million for Q4 2024, and $5.0 million during Q3 2024.